Mario Strazzabosco

Mario Strazzabosco

Auto-generated profile, based on publicly available information

Mario Strazzabosco

Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
CSCarlo Spirlì
Carlo Spirlì
LFLuca Fabris
Luca Fabris
EDElena Duner
Elena Duner
RFRomina Fiorotto
Romina Fiorotto
GBGiorgio Ballardini
Giorgio Ballardini
MSMario Strazzabosco
Mario Strazzabosco

1 June 2002 in Hepatology
Verified
Journal Article
Closed access
PDF file
SMSaida Melero
Saida Melero
CSCarlo Spirlì
Carlo Spirlì
ÁZÁkos Zsembery
Ákos Zsembery
JMJuan F. Medina
Juan F. Medina
RJRuth E. Joplin
Ruth E. Joplin
MSMario Strazzabosco
Mario Strazzabosco
Primary biliary cirrhosis (PBC) is a disorder of unknown origin with autoimmune features. Recently, impaired biliary secretion of bicarbonate has been shown in patients with PBC. Here we have investigated whether bile duct epithelial cells isolated from PBC patients exhibit defects in transepithelial bicarbonate transport by analyzing the activities of 2 ion exchangers, Cl−/HCO− 3 anion exchanger 2 (AE2) and Na+/H+ exchanger (NHE) in isolated cholangiocytes. AE2 and NHE activities were studied in basal conditions and after stimulation with cyclic adenosine monophosphate (cAMP) and extracellular adenosine triphosphate (ATP), respectively. Cholangiocytes were grown from needle liver biopsies from 12 PBC patients, 8 normal controls, and 9 patients with other liver diseases. Also, intrahepatic cholangiocytes were cultured after immunomagnetic isolation from normal liver tissue (n = 6), and from recipients undergoing liver transplantation for end-stage PBC (n = 9) and other forms of liver disease (n = 8). In needle-biopsy cholangiocytes, basal AE2 activity was significantly decreased in PBC as compared with normal livers and disease controls. In addition, we observed that though cAMP increased AE2 activity in cholangiocytes from both normal and non-PBC livers, this effect was absent in PBC cholangiocytes. Similarly, though in cholangiocytes from normal and disease control livers extracellular ATP induced a marked enhancement of NHE activity, cholangiocytes from PBC patients failed to respond to purinergic stimulation. In conclusion, our findings provide functional evidence that PBC cholangiocytes exhibit a widespread failure in the regulation of carriers involved in transepithelial H+/HCO− 3 transport, thus, providing a molecular basis for the impaired bicarbonate secretion in this cholestatic syndrome.

1 May 1986 in Drugs
Verified
Journal Article
Closed access
PDF file
LOLajos Okolicsanyi
Lajos Okolicsanyi
FLFlavio Lirussi
Flavio Lirussi
MSMario Strazzabosco
Mario Strazzabosco
RJRosa Maria Jemmolo
Rosa Maria Jemmolo
RORocco Orlando
Rocco Orlando
GCGaetano Crepaldi
Gaetano Crepaldi

1 July 2005 in Gastroenterology
Verified
Journal Article
Open access
PDF file
CSCarlo Spirlì
Carlo Spirlì
RFRomina Fiorotto
Romina Fiorotto
LSLei Song
Lei Song
JSJoseph Santos-Sacchi
Joseph Santos-Sacchi
LOLajos Okolicsanyi
Lajos Okolicsanyi
MSMario Strazzabosco
Mario Strazzabosco
Background & Aims: Progressive liver disease is a severe complication of cystic fibrosis, a genetic disease characterized by impaired epithelial adenosine 3′,5′-cyclic monophosphate-dependent secretion caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). In the liver, CFTR is expressed in cholangiocytes and regulates the fluid and electrolyte content of the bile. Glibenclamide, a sulfonylurea and a known CFTR inhibitor, paradoxically stimulates cholangiocyte secretion. We studied the molecular mechanisms underlying this effect and whether glibenclamide could restore cholangiocyte secretion in cystic fibrosis. Methods: NRC-1 cells, freshly isolated rat cholangiocytes, isolated rat biliary ducts, and isolated biliary ducts from CFTR-defective mice (Cftrtm1Unc) were used to study fluid secretion (by video-optical planimetry), glibenclamide-induced secretion (by high-performance liquid chromatography in cell culture medium), intracellular pH and intracellular Ca2+ concentration transients [2′7′-bis(2-carboxyethyl)-5,6,carboxyfluorescein-acetoxymethylester and Fura-2 f-AM (5-Oxazolecarboxylic acid, 2-(6-(bis(2-((acetyloxy)methoxy)-2-oxoethyl)amino)-5-(2-(2-(bis(2-((acetyloxy)methoxy)-2-oxoethyl)amino)-5-methylphenoxy)ethoxy)-2-benzofuranyl)-, (acetyloxy)methyl ester) microfluorometry], gene expression (by reverse-transcription polymerase chain reaction), and changes in membrane capacitance (by patch-clamp experiments). Results: Stimulation of cholangiocyte secretion by glibenclamide and tolbutamide required Cl− and was mediated by the sulfonylurea receptor 2B. Glibenclamide-induced secretion was blocked by inhibitors of exocytosis (colchicine, wortmannin, LY294002, and N-ethylmaleimide) and by inhibitors of secretory granule acidification (vanadate, bafilomycin A1, and niflumic acid) but was Ca2+ and depolarization independent; membrane capacitance measurements were consistent with stimulation of vesicular transport and fusion. Glibenclamide, unlike secretin and forskolin, was able to stimulate secretion in Cftrtm1Unc mice, thus indicating that this secretory mechanism was preserved. Conclusions: The ability of glibenclamide to stimulate secretion in CFTR-defective mice makes sulfonylureas a model class of compounds to design drugs useful in the treatment of cystic fibrosis with liver impairment and possibly of other cholestatic diseases.

1 April 2016 in Gastroenterology
Verified
Journal Article
Closed access
MCMassimiliano Cadamuro
Massimiliano Cadamuro
MVMarta Vismara
Marta Vismara
SBSimone Brivio
Simone Brivio
ABAndrea Bovo
Andrea Bovo
MSMario Strazzabosco
Mario Strazzabosco
SNSiew C. Ng
Siew C. Ng

31 December 2000 in The American Journal of Pathology
Verified
Journal Article
Open access
LFLuca Fabris
Luca Fabris
MSMario Strazzabosco
Mario Strazzabosco
HCHeather A. Crosby
Heather A. Crosby
GBGiorgio Ballardini
Giorgio Ballardini
SHStefan G. Hubscher
Stefan G. Hubscher
RJRuth Joplin
Ruth Joplin